Press Releases

12345678910
Odyssey Logistics Names Gerald Hofmann President of Integrated Marine Logistics Division
Odyssey Logistics, a global leader in multimodal logistics, today announced Gerald Hofmann as President of the company’s Integrated Marine Logistics division. With more than 30 years of experience driving growth across global supply chains, Hofmann will lead Odyssey’s multimodal logistics operations across Alaska, Hawaii, Guam, and Puerto Rico including its licensed non-vessel operating common carrier services. Hofmann’s leadership of Odyssey’s presence across important Jones Act lanes positions the company for broad growth while supporting seamless operations across critical U.S. and international shipping routes.
By Odyssey Logistics · Via Business Wire · January 23, 2025
Upshop Strengthens Executive Leadership Team with Appointment of New CRO and COO to Drive Global Growth
Upshop, the leader in store operations technology for food retailers, today announced the appointment of Chris Renda as Chief Revenue Officer (CRO) and Patrick Eichen as Chief Operating Officer (COO). These strategic hires reinforce Upshop's commitment to global expansion and accelerating customer adoption of its enterprise operating platform for food retail.
By Upshop · Via Business Wire · January 23, 2025
Upexi Shifts Focus into Bitcoin and Crypto with Strategic Investment in Digital Currency as Part of Long-Term Strategic Crypto Initiative
Subsidiaries have been organized to invest and capitalize on the opportunities of cryptocurrency including Bitcoin and other coins with high growth potential
Via ACCESS Newswire · January 23, 2025
Revolve Expands Financial Partnership with Export Development Canada
VANCOUVER, BC / ACCESS Newswire / January 23, 2025 / Revolve Renewable Power Corp. (TSXV:REVV)(OTCQB:REVVF) ("Revolve" or the "Company"), a North American owner, operator and developer of renewable energy projects, is pleased to announce an expansion of the Company's Account Performance Security Guarantee ("APSG") facility with Export Development Canada ("EDC"). The expanded APSG with EDC has increased from US$2,900,000 to US$4,500,000.
Via ACCESS Newswire · January 23, 2025
Twin Vee PowerCats Co. Reports Strong Start to 2025 After Difficult Q4 2024
FORT PIERCE, FL / ACCESS Newswire / January 23, 2025 / Twin Vee PowerCats Co. (Nasdaq:VEEE), ("Twin Vee" or the "Company"), a manufacturer, distributor, and marketer of power sport boats, today announced that early indicators from the first few weeks of the year suggest that the demand for Twin Vee's products is rebounding from 2024 levels. Specifically, the Company has seen a noticeable uptick in orders and market activity after a sluggish Q4 last year.
Via ACCESS Newswire · January 23, 2025
Carter Bankshares, Inc. Announces Fourth Quarter and Full Year 2024 Financial Results
MARTINSVILLE, VA / ACCESS Newswire / January 23, 2025 / Carter Bankshares, Inc. (the "Company") (NASDAQCARE), the holding company of Carter Bank (the "Bank") today announced quarterly net income of $8.3 million, or $0.36 diluted earnings per share ("EPS"), for the fourth quarter of 2024 compared to net income of $5.6 million, or $0.24 diluted EPS, for the third quarter of 2024 and a net loss of $1.9 million, or $(0.08) per share, for the fourth quarter of 2023. Pre-tax pre-provision income1 was $5.6 million for the fourth quarter of 2024, $6.8 million for the third quarter of 2024 and $1.6 million for the fourth quarter of 2023.
Via ACCESS Newswire · January 23, 2025
Alphia Names New Vice President of Operations to Leadership Team
Alphia, the largest pet food co-manufacturer in North America, announces the appointment of Cody Risner as Vice President of Operations, effective immediately. In his new role, Risner will continue to leverage his wealth of knowledge and experience to guide the Alphia team to achieve company goals.
By Alphia · Via Business Wire · January 23, 2025
Medidata and Tigermed Renew Strategic Partnership Aimed at Accelerating Clinical Trials Globally
Medidata, a Dassault Systèmes brand and leading provider of clinical trial solutions to the life sciences industry, has extended its 13-year relationship with Tigermed, a leading global provider of clinical research solutions across the full life cycle of global biopharmaceutical and medical device products. This extended partnership will further harness the Medidata Platform from early-phase trials to post-marketing surveillance, to optimize study workflows, ensure regulatory compliance, and improve the speed of delivering new therapies to patients worldwide, including the emerging markets.
By Medidata · Via Business Wire · January 23, 2025
Mental Health Savings Calculator Powered by TARA Mind Launches to Help Employers Combat Corporate America’s $193 Billion Treatment-Resistant Depression (TRD) Crisis
TARA Mind, a leader in transformative mental health solutions, is taking decisive action to address the mounting mental health crisis in the U.S. workforce with the launch of its new Mental Health Savings Calculator.
By TARA Mind · Via Business Wire · January 23, 2025
Parabilis Medicines to Present Trial-in-Progress Poster on Phase 1/2 Study of FOG-001, a β-cateninTCF4 Inhibitor, at ASCO Gastrointestinal Cancers Symposium
Parabilis Medicines (formerly Fog Pharmaceuticals), a clinical-stage biopharmaceutical company dedicated to creating extraordinary medicines for people living with cancer, today announced the presentation of a trial-in-progress poster on the Company’s first-in-human clinical trial evaluating FOG-001, the first and only direct inhibitor of β-cateninTCF4, at the American Society of Clinical Oncology (ASCO) Gastrointestinal Cancers Symposium taking place in San Francisco from January 23-25, 2025.
By Parabilis Medicines · Via Business Wire · January 23, 2025
Thoughtworks Named a Leader and a Customer Favorite in Modern Application Development Services by Leading Independent Research Firm
Thoughtworks, a global technology consultancy that integrates strategy, design and engineering to drive digital innovation, announced today that leading global research and advisory firm Forrester recognized it as a Leader in Modern Application Development (MAD) Services. Thoughtworks was also named a Customer Favorite in this Forrester Wave evaluation for outstanding customer feedback.
By Thoughtworks · Via Business Wire · January 23, 2025
BAI Connect and eero Bring Next Generation Wi-Fi Technology to Denver’s Dynamic Multi-Family Market
BAI Connect, the fastest-growing internet solutions provider for multifamily communities across the western United States, has teamed up with Broe Real Estate Group and eero, an Amazon company, to debut its industry leading Wi-Fi platform in the vibrant Denver multifamily market. Broe’s award-winning Country Club Tower luxury living community has been selected to feature BAI Connect’s newly launched 10-gig symmetrical network. The 558-unit property in Denver’s exclusive Washington Park neighborhood is the first luxury living community within Broe Real Estate Group’s multifamily portfolio to deploy BAI Connect’s future-ready technology.
By BAI Connect · Via Business Wire · January 23, 2025
McKesson’s Practice Insights Selected as a 2025 Qualified Clinical Data Registry by Centers for Medicare & Medicaid Services
For the ninth consecutive year, the Centers for Medicare & Medicaid Services (CMS) has named McKesson a Qualified Clinical Data Registry (QCDR) approved to participate in the Merit-based Incentive Payment System (MIPS). As a CMS-designated QCDR, McKesson can collect and report clinical data on behalf of clinicians utilizing iKnowMed℠ electronic health record and integrated module, Practice Insights℠, a performance analytics tool powered by Ontada®, McKesson’s technology and insights business. The designation enables healthcare practices and providers utilizing iKnowMed to efficiently submit data directly for both MIPS and custom QCDR quality measures to CMS, eliminating the need to engage a separate registry vendor, streamlining data submission and minimizing administrative burden.
By McKesson · Via Business Wire · January 23, 2025
Apex and Great River Energy Sign Offtake Agreement with Innovative Solution to Transmission Constraints
Apex Clean Energy today announced a power purchase agreement (PPA) and surplus interconnection service agreement (SISA) with electric cooperative Great River Energy for the 300 MW Big Bend Wind. This transaction represents the first PPA and SISA executed by Apex with the same counterparty, an approach that leverages the cooperative’s existing injection rights with MISO to bypass traditional interconnection hurdles and expedite project development.
By Apex Clean Energy · Via Business Wire · January 23, 2025
Riveron Announces Partnership with Alteryx, Helping CFOs and Business Leaders Simplify Their Data Complexities
Riveron, a leading business advisory firm specializing in business transformation and value creation for CFOs, private equity firms, and key stakeholders, formalized a partnership with Alteryx. The business advisory firm has a successful track record of helping companies with financial transformations and technology enablement, offering a full suite of solutions focused on the office of the CFO, mergers and acquisitions, and distress. Through this new partnership, Riveron will help businesses implement and use Alteryx for reporting, analytics, and other business transformation purposes.
By Riveron · Via Business Wire · January 23, 2025
Amneal Receives U.S. FDA Approval for Memantine/Donepezil Extended-Release Capsules and Everolimus Tablets for Oral Suspension, and Tentative U.S. FDA Approval for Rifaximin
Amneal Pharmaceuticals, Inc. (Nasdaq: AMRX) (“Amneal” or the “Company”) today announced that the U.S. Food and Drug Administration (FDA) has approved memantine/donepezil 14-10 mg and 28-10 mg extended-release capsules, which references Abbvie’s NAMZARIC®, and Everolimus 2 mg, 3 mg and 5 mg extended-release capsules, which references Novartis’ AFINITOR DISPERZ®. In addition, the FDA has granted tentative approval to Amneal’s rifaximin 550 mg oral tablets, which references Bausch Health’s XIFAXAN®. The FDA approval was tentative as this product is involved in litigation.
By Amneal Pharmaceuticals, Inc. · Via Business Wire · January 23, 2025
Firefly’s Blue Ghost Spacecraft Begins Journey to Moon, Supported by Rocket Lab Software and Components
Rocket Lab USA, Inc. (Nasdaq: RKLB) (“Rocket Lab” or “the Company”), a global leader in launch services and space systems, celebrates the successful launch of Firefly Aerospace’s Blue Ghost Mission 1. Rocket Lab is supporting Blue Ghost’s 45-day journey to the Moon with the Company’s MAX Flight and MAX Ground Data Software suites.
By Rocket Lab USA, Inc. · Via Business Wire · January 23, 2025
Survey Reveals Americans Are Worried About Heart Attacks; Devout Football Fandom May Bring Greater Risk to Their Heart Health
New research conducted by YouGov on behalf of Siemens Healthineers1 reveals Americans’ devotion to football fandom could put their heart health at risk. According to the survey, roughly 1 in 5 Americans (21%) would hesitate to leave a professional sporting event to go to the hospital if they suspected they were having a heart attack. Among American football fans, however, 28% would hesitate to leave a professional sporting event to go to the hospital if they suspected they were having a heart attack. This number only declined to 19% among football fans who themselves have already visited the ER with symptoms of a heart attack.
By Siemens Healthineers · Via Business Wire · January 23, 2025
Astria Therapeutics Announces Initiation of Phase 1a Trial of STAR-0310, a Potential Best-in-Class Monoclonal Antibody OX40 Antagonist for the Treatment of Atopic Dermatitis
Astria Therapeutics, Inc. (NASDAQATXS), a biopharmaceutical company focused on developing life-changing therapies for allergic and immunologic diseases, today announced initiation of a Phase 1a clinical trial of STAR-0310 in healthy subjects. STAR-0310, a high affinity monoclonal antibody OX40 antagonist that incorporates YTE technology, is in development for the potential treatment of atopic dermatitis (AD) and potentially other indications. The Phase 1a trial is intended to assess the safety, tolerability, pharmacokinetics, and immunogenicity of STAR-0310 in healthy adult participants. Astria expects early proof-of-concept results from the Phase 1a trial in the third quarter of 2025.
By Astria Therapeutics, Inc. · Via Business Wire · January 23, 2025
Revvity Ignites Scientific Breakthroughs at SLAS2025
Revvity, Inc. is set to unveil its groundbreaking new Phenologic.AI™ software at SLAS2025 in San Diego, January 27-29. Designed to redefine cellular imaging workflows for Revvity’s Harmony™ and Signals Image Artist™ software packages, the Phenologic.AI software leverages pre-trained deep-learning models to analyze brightfield images, providing an additional multiplexing channel and streamlined workflows for live cell analysis. This significant advancement expands the possibilities for understanding cellular behaviors and disease mechanisms. The Phenologic.AI offering provides scalable, efficient, and objective analysis and can be integrated with Revvity Signals Research Suite™ to provide more in-depth data analytics.
By Revvity · Via Business Wire · January 23, 2025
Qdrant Launches the First Platform-Independent GPU-Accelerated Vector Indexing for Real-Time AI Applications
Qdrant, the leading high-performance open-source vector database, today introduced its platform-independent GPU-accelerated vector indexing. This new feature delivers up to 10x faster index-building times while leveraging cost-effective GPUs that rival or surpass CPUs in both cost and efficiency. With support for GPU acceleration across multiple platforms, Qdrant empowers developers to scale real-time AI applications flexibly and free from hardware vendor constraints.
By Qdrant · Via Business Wire · January 23, 2025
Eagle Crusher Co. Introduces Its Next Generation 1200-CC Crushing and Screening Plant at World of Asphalt/AGG1
Eagle Crusher Co., a leading manufacturer and new product innovator in the crushing and screening industry, will introduce its next generation 1200-CC portable crushing and screening plant, on display in Booth 1912 at World of Asphalt/AGG1, March 25-27, 2025 in St. Louis, Mo.
By Eagle Crusher Co. · Via Business Wire · January 23, 2025
Cass Information Systems Reports Fourth Quarter 2024 Results
Cass Information Systems, Inc. (Nasdaq: CASS), (the Company or Cass) reported fourth quarter 2024 earnings of $0.33 per diluted share, as compared to $0.61 in the fourth quarter of 2023 and $0.21 in the third quarter of 2024. Net income for the period was $4.6 million, a decrease of 45.4% from $8.4 million in the same period in 2023 and an increase of $2.9 million, or 56.4%, as compared to the third quarter of 2024. For the year ended December 31, 2024, the Company reported net income and earnings per diluted share of $19.2 million and $1.39, respectively, as compared to $30.1 million and $2.18, respectively, for the year ended December 31, 2023.
By Cass Information Systems, Inc. · Via Business Wire · January 23, 2025
NovaBay Pharmaceuticals Completes the Sale of its Eyecare Business to PRN and Further Adjourns its Special Meeting of Stockholders on Dissolution Proposal
NovaBay® Pharmaceuticals, Inc. (NYSE American: NBY) (“NovaBay” or the “Company”) announces the completion of the sale of its Avenova eyecare business and related assets to PRN Physician Recommended Nutriceuticals, LLC (“PRN”) for $11.5 million (the “Asset Sale”). The Asset Sale, representing substantially all of the assets of the Company, was consummated pursuant to the Asset Purchase Agreement dated September 19, 2024, as amended, which NovaBay stockholders approved at the Special Meeting of Stockholders (“Special Meeting”) reconvened on January 16, 2025. The Special Meeting has been further adjourned by the Company until January 30, 2025 at 11:00 a.m. Pacific time to allow additional time for stockholders to vote only on the last remaining proposal, Proposal Two, to approve the Company’s liquidation and dissolution (the “Dissolution”) pursuant to the Plan of Complete Liquidation and Dissolution of the Company (the “Plan of Dissolution”).
By NovaBay Pharmaceuticals, Inc. · Via Business Wire · January 23, 2025
Silicon Valley Veterans Launch Lanai: The Enterprise AI Navigation System
Enterprise software veterans Lexi Reese (former COO of Gusto, Google executive) and Dr. Stephen Herrod (former VMware CTO, Juxtapose partner) have launched Lanai with $10 million in seed funding to transform how enterprises navigate AI adoption. The company also announced infrastructure pioneer Rajesh Raman (Google, Meta, Splunk) as Chief Technology Officer.
By Lanai · Via Business Wire · January 23, 2025
CommerceHealthcare® Releases 2025 Healthcare Finance Trends Report
CommerceHealthcare® has released its sixth annual Healthcare Finance Trends and Insights Report. The report includes an in-depth analysis of research combined with practice experience and identifies high-impact trends for the healthcare industry in 2025. It captures the following themes across four planning sectors:
By CommerceHealthcare · Via Business Wire · January 23, 2025
Amazon, Costco, and UPS Rank Highest in Caliber’s U.S. Trust & Like Poll
Caliber, a stakeholder intelligence company helping brands build trust, released its annual U.S. Fortune 30 Most Trusted & Liked Companies Survey, finding that Amazon, Costco, and UPS have the best corporate reputation among the biggest listed companies in the United States in 2024, just ahead of well-respected brands like FedEx and Lowe’s. The same study also found that significantly more companies fell in the Trust & Like Score (TLS) ranking, compared to years past, when reputation scores have risen or remained neutral.
By Caliber · Via Business Wire · January 23, 2025
Carter Bank and Federal Home Loan Bank of Atlanta Award More Than $2 Million to Support Affordable Housing in North Carolina
MARTINSVILLE, Va., Jan. 23, 2025 (GLOBE NEWSWIRE) -- Carter Bank (Nasdaq: CARE) and the Federal Home Loan Bank of Atlanta (FHLBank Atlanta) announced today a significant investment of $2.3 million in grant funding, designated for three separate projects that will create 168 new affordable housing units across North Carolina.
By Federal Home Loan Bank of Atlanta · Via GlobeNewswire · January 23, 2025
LOGE Camps Partners With Schulte Hospitality Group
LOGE Camps, a leader in unique outdoor-inspired lodging experiences, and Schulte Hospitality Group (SHG), a prominent hotel management company, are pleased to announce the formation of a new partnership that is focused on the brand and operational growth of LOGE Camps' existing 18 hotels and its expanding portfolio of hotels across the United States. The partnership leverages LOGE Camps' innovative approach to blending outdoor exploration with comfortable, affordable lodging, and SHG's deep industry experience, financial strength, and proven track record in hotel management. This collaboration will expand the reach and increase operational efficiencies across LOGE Camps' current and future locations, ensuring a seamless experience for guests and employees, and a stronger presence in the outdoor hospitality market.
By Schulte Hospitality Group · Via Business Wire · January 23, 2025
Pebblebrook Hotel Trust Announces the 13th Annual Pebby Award Nominations
Pebblebrook Hotel Trust (NYSEPEB) (the “Company” or “Pebblebrook”) today announced its nominations for the Thirteenth Annual Pebby Awards. The Pebby Award nominees were chosen for their outstanding accomplishments in 2024, as determined by Pebblebrook’s selection committee.
By Pebblebrook Hotel Trust · Via Business Wire · January 23, 2025
Family History Newcomer, Storied, Announces Acquisition of AI Innovator Memory Lane and Rolls Out Affordable Pricing
Storied, a leader in family history and digital storytelling, is thrilled to announce its strategic acquisition of Memory Lane, an artificial intelligence company known for its advanced memory capture technologies.
By Storied · Via Business Wire · January 23, 2025
Nicoya Launches Alto Automation Suite to Facilitate SPR Integration Into High-Throughput Biologics Discovery Workflows
Nicoya®, a pioneering life science instrument company specializing in innovative biosensor technologies, announces the launch of the Alto Automation Suite™ for its flagship Alto™ Digital SPR™ system. This makes Alto the world’s first SPR platform that is fully compatible with standard lab automation, enabling thousands of samples per week to be run without human intervention.
By Nicoya Lifesciences · Via Business Wire · January 23, 2025
PennyMac Financial Services, Inc. Announces Date for Release of Fourth Quarter and Full-Year 2024 Results
PennyMac Financial Services, Inc. (NYSEPFSI) will announce results for the quarter and year ended December 31, 2024, in a news release to be issued after the market close on Thursday, January 30, 2025. Management will also host a conference call and live audio webcast at 5:00 p.m. Eastern Time to review the results.
By PennyMac Financial Services, Inc. · Via Business Wire · January 23, 2025
PennyMac Mortgage Investment Trust Announces Date for Release of Fourth Quarter and Full-Year 2024 Results
PennyMac Mortgage Investment Trust (NYSEPMT) will announce results for the quarter and year ended December 31, 2024, in a news release to be issued after the market close on Thursday, January 30, 2025. Management will host a conference call and live audio webcast at 6:00 p.m. Eastern Time to review the results.
WisdomTree Announces Say Platform for Fourth Quarter 2024 Earnings is Live
WisdomTree, Inc. (NYSEWT), a global financial innovator, announced today that Say, a stockholder Q&A platform, is live and ready to be used in advance of its upcoming fourth quarter earnings call on Friday, January 31, 2025 at 11:00 a.m. ET.
By WisdomTree, Inc. · Via Business Wire · January 23, 2025
Bahwan CyberTek’s Digital Group (“BCT EXP”) Forges Global Partnership with OutSystems to Drive the Future of Application Development.
BCT EXP, a global leader in digital transformation, user experiences, cross platform technologies and enterprise systems, today announced a formal partnership with OutSystems, a recognized pioneer in AI-powered low-code application development, designed to empower organizations worldwide with cutting-edge digital solutions and experiences.
By Bahwan CyberTek Group · Via Business Wire · January 23, 2025
MilliporeSigma Partners with Opentrons Labworks, Inc., Supporting Lab of the Future
MilliporeSigma, the U.S. and Canada Life Science business of Merck KGaA, Darmstadt, Germany, and Opentrons Labworks, Inc., a leader in lab automation and accessible robotics, announced a multi-year agreement to automate assay kits on a custom Opentrons Flex® workstation.
By MilliporeSigma · Via Business Wire · January 23, 2025
Lisata Therapeutics and WARPNINE Announce Encouraging Preliminary Results from the Phase 1b/2a iLSTA Trial Evaluating Certepetide in Locally Advanced Non-Resectable Pancreatic Ductal Adenocarcinoma
Data corroborate previously reported preclinical data demonstrating certepetide’s ability to enhance the effectiveness of immunotherapy
By Lisata Therapeutics, Inc. · Via GlobeNewswire · January 23, 2025
LiveOne's (Nasdaq: LVO) Tesla Partnership Surpasses Projections with Over 600,000 Users, 33% Increase Since Jan. 1st
- New Users Include 275K+ Ad-Supported
By Liveone, Inc. · Via GlobeNewswire · January 23, 2025
NOVAGOLD Files Year-End 2024 Report with Strong Treasury to Fund Key Activities for Long-Term Value Creation
VANCOUVER, British Columbia, Jan. 23, 2025 (GLOBE NEWSWIRE) -- NOVAGOLD RESOURCES INC. (“NOVAGOLD” or “the Company”) (NYSE American, TSX: NG) today filed its 2024 fiscal year-end report and provided an update on its Tier One1 gold development project, Donlin Gold, which NOVAGOLD owns equally with Barrick Gold Corporation (“Barrick”).
By NOVAGOLD RESOURCES INC. · Via GlobeNewswire · January 23, 2025
Over 30 McDonald's and Wendy’s Locations in Northern Illinois Partner with Perch Energy to Enroll in Community Solar, Estimated $1M in Savings Over Time
Illinois-based Franchisee Takes Major Step Toward Sustainability and Cost-Savings by Joining Illinois Community Solar Farms
By Perch Energy · Via GlobeNewswire · January 23, 2025
Conduit Pharmaceuticals Inc. Announces Reverse Stock Split
NAPLES, Fla. and CAMBRIDGE, United Kingdom, Jan. 23, 2025 (GLOBE NEWSWIRE) -- Conduit Pharmaceuticals Inc. (Nasdaq: CDT) (“Conduit” or the “Company”), a multi-asset, clinical stage, disease-agnostic life science company delivering an efficient model for compound development, announces that its board of directors has approved a 1-for-100 reverse stock split of the Company’s common stock. The Company’s stockholders approved the reverse stock split proposal at the Company’s Annual Meeting of Stockholders held on December 18, 2024. They granted the board of directors the authority to determine the exact split ratio and when to proceed with the reverse stock split.
By Conduit Pharmaceuticals · Via GlobeNewswire · January 23, 2025
ALX Oncology Presents Positive Updated Data from ASPEN-06 Phase 2 Trial Demonstrating Evorpacept Generates Strong Response and Durable Clinical Benefit in Patients with HER2-Positive Gastric Cancer
SOUTH SAN FRANCISCO, Calif., Jan. 23, 2025 (GLOBE NEWSWIRE) -- ALX Oncology Holdings Inc., (“ALX Oncology” or the “Company”) (Nasdaq: ALXO), a clinical-stage biotechnology company advancing therapies that boost the immune system to treat cancer and extend patients’ lives, announced positive updated data from the ASPEN-06 Phase 2 clinical trial demonstrating that the company’s investigational CD47-blocker evorpacept generates a durable clinical response with a well-tolerated safety profile among patients with previously treated HER2-positive advanced gastric cancer (GC) or gastroesophageal junction (GEJ) cancer. The updated results, which build upon previously announced topline results, will be shared today in an oral presentation (Abstract #332) at the 2025 American Society of Clinical Oncology (ASCO) Gastrointestinal Cancers Symposium in San Francisco.
By ALX Oncology · Via GlobeNewswire · January 23, 2025
Sunrun Announces Date for Fourth Quarter and Full-year 2024 Earnings Report
Earnings Release and Conference Call Scheduled for February 27, 2025
By Sunrun Inc. · Via GlobeNewswire · January 23, 2025
NCMS Report Highlights Advanced Manufacturing Processes for Vehicle Lightweighting
ANN ARBOR, Mich., Jan. 23, 2025 (GLOBE NEWSWIRE) -- The National Center for Manufacturing Sciences (NCMS) announces the publication of a new Technology Brief that highlights recent advances in vehicle lightweighting.
Shepherd Ave Capital Acquisition Corporation Announces the Separate Trading of its Class A Ordinary Shares and Rights, Commencing on January 27, 2025
Wilmington, DE, Jan. 23, 2025 (GLOBE NEWSWIRE) -- Shepherd Ave Capital Acquisition Corporation (the “Company”) (Nasdaq: SPHAU), a blank check company, today announced that, commencing on January 27, 2025, holders of the 8,625,000 units (the “Units”) sold in the Company’s initial public offering (the “Offering”) including Units sold upon the full exercise of the underwriters’ over-allotment option, may elect to separately trade the Class A ordinary shares and rights included in the Units. Any Units not separated will continue to trade on the NASDAQ Global Market (“NASDAQ”) under the symbol “SPHAU.” Any underlying Class A ordinary shares and rights that are separated will trade on the NASDAQ under the symbols “SPHA” and “SPHAR,” respectively. Holders of Units will need to have their brokers contact the Company’s transfer agent, Vstock Transfer, LLC, in order to separate the holders’ Units into Class A ordinary shares and rights.
Basetwo Raises $11.5M Series A to Transform Chemical Manufacturing with Physics AI Platform
TORONTO, Jan. 23, 2025 (GLOBE NEWSWIRE) -- Basetwo, an AI platform for manufacturing engineers, today announced it has raised USD $11.5M in Series A funding led by AVP with participation from existing investor Glasswing Ventures, Deloitte Ventures, Global Brain Ventures, Shimadzu Corporation, Chiyoda Corporation, and prominent UAE angel investors via Qora71. The investment allows the company to accelerate its mission to revolutionize how pharmaceutical and chemical manufacturers optimize their production processes.
By Basetwo · Via GlobeNewswire · January 23, 2025
Fengate announces final close of US$1.1 billion flagship infrastructure fund above target
TORONTO, Jan. 23, 2025 (GLOBE NEWSWIRE) -- Fengate Asset Management (‘Fengate’) today announced the final close of its flagship closed-ended infrastructure fund, Fengate Infrastructure Fund IV (‘Fund IV’ or ‘the Fund’) at US$1.1 billion, exceeding its fundraising target.
By Fengate Asset Management · Via GlobeNewswire · January 23, 2025
New Survey - 69% of Shoppers Buy While Multitasking—Is Retail Ready for the Always-On Consumer?
AI tools, viral trends, and live shopping are fueling seismic shifts in consumer behavior, according to Salsify’s 2025 Consumer Research Report
By Salsify · Via GlobeNewswire · January 23, 2025
Summit Ridge Energy Partners with OSF HealthCare to Deliver $9 Million in Energy Savings
The 20-year agreement will deliver an average of $450,000 in annual energy savings across the healthcare system. The partnership brings more than 24 megawatts of distributed solar energy to local grids in Illinois, supporting the state’s resiliency goals.
By Summit Ridge Energy · Via GlobeNewswire · January 23, 2025